Found 37 matching trials
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC PHASE2 This study aims to observe and explore the efficacy and safety of Penpulima...
Show More Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma PHASE3 This is a randomized, controlled, open-label, multicenter study to evaluate...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma PHASE3 This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Show More Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Learn More & Join Trial
A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor PHASE2 This study is designed to evaluate the efficacy and safety of Anlotinib com...
Show More Learn More & Join Trial
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma PHASE3 This study is a randomized, double-blind, multi-center phase III clinical s...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers PHASE1 TQB3602 is a kind of proteasome inhibitor, AK105 is an anti-programmed cell...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy PHASE2 This study is a two arm, randomized, prospective, multicenter study on the ...
Show More Location
The First Affiliated Hospital of the Air Force Medical University
Learn More & Join Trial
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors PHASE1 This study is to characterize the safety, tolerability, pharmacokinetics (P...
Show More Location
St Vincent's Hospital, Sydney (The Kinghorn Cancer Centre)
Learn More & Join Trial
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. PHASE2 This is a prospective, open-label single-arm, exploratory, two-stage design...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003 PHASE2 A single-arm, open-label clinical trial, focus on the safety and efficacy o...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial